Contributors

Jame Abraham, MD, FACP Director, Breast Oncology Program, Taussig Cancer Institute, Professor of Medicine, Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio

David J. Adelstein, MD Professor, Department of Medicine, Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio; Staff, Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio

Piyush K. Agarwal, MD Head, Bladder Cancer Section, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Tenure-Track Investigator, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Sanjiv S. Agarwala, MD Professor, Temple University School of Medicine, Philadelphia, Pennsylvania; Chief of Medical Oncology and Hematology; Director, Melanoma and Immunology Program, St. Luke’s Cancer Center, Easton, Pennsylvania

Christina M. Annunziata, MD, PhD Investigator, Women’s Malignancies Branch, National Cancer Institute, Bethesda, Maryland

Andrea B. Apolo, MD Chief, Bladder Cancer Section, Investigator and Lasker Scholar, Center for Cancer Research, Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Ananth K. Arjunan, MD Fellow, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania

Philip M. Arlen, MD Attending Physician, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Ann Berger MSN MD Chief of Pain and Palliative Care, National Institutes of Health, Clinical Center, Bethesda, Maryland

Christina Brzezniak, DO Chief of Thoracic Oncology, John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, Maryland

Brian Burkey, MD Professor, Otolaryngology—Head and Neck Surgery, Vice-Chairman, Head and Neck Institute, Cleveland Clinic and Foundation, Cleveland, Ohio

George Carter, MMS PA-C National Institutes of Health, NCL, Medical Oncology Branch, Bethesda, Maryland

Julia Cheringal, MD Medical Oncology Fellow, John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, Maryland

Michael Craig, MD Professor, Department of Medicine, Section Chief, West Virginia University Cancer Institute, Morgantown, West Virginia

William L. Dahut, MD Senior Investigator, Genitourinary Malignancies Branch, National Institutes of Health, Bethesda, Maryland

Erin F. Damery, PharmD, BCOP Clinical Oncology Pharmacist, Pharmacy Department, University of Kansas Health System, Kansas City, Kansas

Robert Dean, MD Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

Jaydira Del Rivero, MD Staff Clinician, Medical Oncology Service, Center for Cancer Research, National Cancer Institutes, National Institutes of Health, North Bethesda, Maryland

Marnie Grant Dobbin, MS, RDN, CNSC Clinical Research Dietitian, Nutrition Department, National Institutes of Health, Bethesda, Maryland

Daniel E. Elswick, MD, FAPM Clinical Associate Professor, Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, West Virginia

Bassam Estfan, MD Assistant Professor of Medicine, Taussig Cancer Institute, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Staff, Hematology/Oncology, Cleveland Clinic, Cleveland, Ohio

Sheryl B. Fleisch, MD Assistant Professor, Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee

Juan C. Gea-Banacloche, MD Senior Clinician, Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Chief, Infectious Diseases Consultation Service, NIAID/NCI, NIH Clinical Center, Bethesda, Maryland

Thomas J. George, Jr., MD, FACP Associate Professor, Department of Medicine, University of Florida, Gainesville, Florida; Director, GI Oncology Program, Department of Medicine, University of Florida Health Cancer Center, Gainesville, Florida

Aaron T. Gerds, MD, MS Assistant Professor of Medicine, Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio; Staff, Leukemia Program, Cleveland Clinic, Cleveland, Ohio

Azam Ghafoor, MD Oncology Fellow, Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland

Mark R. Gilbert, MD Senior Investigator and Chief, Neuro-Oncology Branch, National Institutes of Health/National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Ann W. Gramza, MD Medical Oncologist, Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

Megan Greally MB, BCh, BAO Advanced Oncology Fellow, Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, New York

F. Anthony Greco, MD Director Sarah Cannon Cancer Center, Centennial Medical Center Sarah Cannon Cancer Center, Nashville, Tennessee

James L. Gulley, MD, PhD, FACP Director, Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Formerly of Emory University School of Medicine, and Loma Linda University School of Medicine

Mehdi Hamadani, MD Associate Professor of Medicine, Hematology/Oncology, CIBMTR & Medical College of Wisconsin, Milwaukee, Wisconsin; Director, Blood and Marrow Transplant Program, Hematology/Oncology, Froedtert Hosptial, Milwaukee, Wisconsin

Hannah W. Hazard-Jenkins, MD, FACS Associate Professor, Department of Surgery, Director of Clinical Services, WVU Cancer Institute, West Virginia University Hospital, Morgantown, West Virginia

Brandie Heald, MS, LGC Licensed Genetic Counselor, Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio

Upendra P. Hegde, MD Associate Professor, Department of Medicine, University of Connecticut, Farmington, Connecticut; Associate Director, Melanoma and Cutaneous Oncology Program, Neag Comprehensive Cancer Center, John Dempsey Hospital, Farmington, Connecticut

Thomas E. Hughes, PharmD, BCOP Clinical Pharmacy Specialist, Pharmacy Department, National Institutes of Health, Clinical Research Center, Bethesda, Maryland

Nikhil P. Joshi, MD Assistant Professor of Medicine, Cleveland Clinic, Lerner College of Medicine, Cleveland, Ohio; Staff Physician, College of Medicine, California; Staff Physician, Department of Radiation Oncology, Cleveland Clinic Foundation, California

Matt Kalaycio, MD Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

Abraham S. Kanate, MD Assistant Professor of Internal Medicine, Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, West Virginia

Alok A. Khorana, MD, FACP Professor of Medicine, Taussig Cancer Institute, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Staff, Hematology/Oncology, Cleveland Clinic, Cleveland, Ohio

David R. Kohler, PharmD Oncology Clinical Pharmacy Specialist, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland

Elise C. Kohn, MD, CAPT (ret), USPHS Head, Gynecologic Cancer Therapeutics, Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland

Megan Kruse, MD Department of Hematology-Oncology, Cleveland Clinic, Cleveland, Ohio

Chaoyuan Kuang, MD, PhD Fellow, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania; Fellow, Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Shaji K. Kumar, MD. Professor of Medicine, Consultant, Division of Hematology, Chair, Dysproteinemia Group; Medical Director, Cancer Clinical Research Office, Rochester, Minnesota

Charles A. Kunos, MD, PhD Medical Officer and Coordinator, Investigational Therapeutics & Radiation, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, Maryland

Arjun Lakshman, MD, MRCP Post-doctoral Research Fellow, Division of Hematology, Mayo Clinic, Rochester, Minnesota; Post-doctoral Research Fellow, Division of Hematology, Mayo Clinic, Rochester, Minnesota

Paulette Lebda, MD Department of Radiology, Cleveland Clinic, Cleveland, Ohio

James J. Lee, MD, PhD Associate Professor of Medicine, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Jung-min Lee, MD Investigator and Lasker Clinical Research Scholar, Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

Gregory D. Leonard University Hospital Galway, Galway, Ireland

Ravi A. Madan, MD Clinical Director of the Genitourinary Malignancies Branch at the National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Bindu Manyam, MD Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio

Christopher Melani, MD Staff Clinician, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Staff Clinician, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Lekha Mikkilineni, MD, MA Fellow in Hematology/Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Clinical Fellow, National Cancer Institute, Clinical Center - NIH, Bethesda, Maryland

Emanuela Molinari Neurology Department, Neuroscience Division, The Queen Elizabeth University Hospital, Glasgow, United Kingdom; Consultant Neurologist, Neurology, The Queen Elizabeth University Hospital, Glasgow, United Kingom

Andreas Niethammer, MD, PhD Associate Professor of Experimental Oncology, Department of Radiation Oncology, Ruprecht-Karls-Universitaet Heidelberg, Heidelberg, Germany

Michelle A. Ojemuyiwa, MD Assistant Professor, Department of Medicine, Hematology Oncology Uniformed Services, University of Health Sciences Walter Reed National Military Medical Center, Bethesda, Maryland

Maryland Pao, MD Clinical Professor, Department of Psychiatry, Georgetown University School of Medicine, Washington, DC; Clinical & Deputy Scientific Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland

Hiral Parekh, MD, MPH Assistant Professor, Department of Medicine, University of Florida, Gainesville, Florida; Oncologist, Department of Medicine, University of Florida Health Cancer Center, Gainesville, Florida

Holly Jane Pederson, MD Associate Professor, Medicine, Cleveland Clinic, Lerner College of Medicine, Cleveland, Ohio; Director, Medical Breast Services, Breast Services, Department of General Surgery, Cleveland Clinic, Cleveland, Ohio

Jean-Paul Pinzon, DO Medical Director, Palliative Care, Inova Schar Cancer Institute, Fairfax, Virginia

Muzaffar H. Qazilbash, MD Professor of Medicine, Stem Cell Transplantation and Cellular Therapy, University of Texas, MD Anderson Cancer Center, Houston, Texas

Jason M. Redman, MD Medical Oncology Fellow, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Kevin R. Rice, MD Associate Professor of Surgery, Urology Service Uniformed Services, University of Health Sciences, Walter Reed National Military Medical Center, Bethesda, Maryland

Mark Roschewski, MD Staff Clinician, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Staff Clinician, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Donald L. Rosenstein, MD Professor and Vice Chair for Hospital Psychiatry, Psychiatry and Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Director, Comprehensive Cancer Support Program, North Carolina Cancer Hospital, Chapel Hill, North Carolina

Inger L. Rosner, MD Associate Professor, Department of Surgery, Uniformed Services University, Bethesda, Maryland; Director, Urologic Oncology, Department of Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland

Kerry Ryan, MPH, MS PA-C National Institutes of Health, NHLBI, Pulmonary Branch, Bethesda, Maryland.

Meena Sadaps, MD Medical Resident, Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Yogen Saunthararajah, MD Professor of Medicine, Hematology and Oncology, Case Western Reserve University, Cleveland, Ohio; Staff, Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio

Mikkael A. Sekeres, MD, MS Professor of Medicine, Director, Leukemia Program, Cleveland Clinic, Cleveland, Ohio; Director, Leukemia Program, Cleveland Clinic, Cleveland, Ohio

Chirag Shah, MD Associate Professor, Department of Radiation Oncology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio; Staff Physician, Director of Clinical Research, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio

Dale R. Shepard, MD, PhD Director, Taussig Cancer Institute Phase I and Sarcoma Programs; Staff, Hematology and Medical Oncology and Center for Geriatric Medicine, Cleveland Clinic, Cleveland, Ohio; Assistant Professor of Medicine, Internal Medicine, Cleveland Clinic, Lerner College of Medicine, Cleveland, Ohio; Director, Taussig Institute Phase I and Sarcoma Programs, Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio

Davendra P. S. Sohal, MD, MPH Assistant Professor of Medicine, Taussig Cancer Institute, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Staff, Hematology/Oncology, Cleveland Clinic, Cleveland, Ohio

Ramaprasad Srinivasan, MD, PhD Investigator and Head, Molecular Cancer Section, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

Samer A. Srour, MB ChB, MS Assistant Professor of Medicine, Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Hematology and Oncology Section, Baylor College of Medicine, Houston, Texas

Jason S. Starr, DO Assistant Professor, Department of Medicine, University of Florida, Gainesville, Florida; Oncologist, Department of Medicine, University of Florida Health Cancer Center, Gainesville, Florida

James P. Stevenson, MD Vice-Chairman, Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio

Julius Strauss, MD Staff Clinician, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Christina Tafe, MSN, ACNP-BC, ACHPN Nurse Practitioner, Advanced Disease Management, Heartland Care Partners, Fairfax, Virginia

Sarah M. Temkin, MD Professor, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia; Division Director, Gynecologic Oncology, Virginia Commonwealth University, Richmond, Virginia

Anish Thomas, MBBS, MD Investigator, Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland

Neel Trivedi, MD Hematology/Oncology Fellow, Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Washington, DC

Chaitra Ujjani, MD Associate Professor, Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Washington, DC

Stephanie Valente, DO Department of Surgery, Cleveland Clinic, Cleveland, Ohio

Leticia Varella, MD Assistant Professor, Department of Medicine, Division of Hematology & Oncology, Weill Cornell Medicine, Cornell University, New York, New York

Andrew Vassil, MD Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio

Christopher E. Wee, MD Chief Medical Resident, Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Kristen P. Zeligs, MD Gynecologic Oncologist, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, Maryland

Peter A. Zmijewski, MD Chief Resident, West Virginia University General Surgery Residency, West Virginia University School of Medicine, Morgantown, West Virginia